summit trial tirzepatide Reaching the SUMMIT? Benefits and potential risks associated with the use of in heart failure with preserved ejection fraction Has Tirzepatide Scaled the HFpEF/Obesity

Optimal ApoB levels: For primary prevention (people without established heart disease), optimal ApoB is generally below 90 mg/dL, ideally below 80 mg/dL

Systematic review of in-vivo neuro magnetic resonance spectroscopy for the assessment of posttraumatic stress disorder

New Yorkbased dermatologist Michele Green, MD, recommends this gentle formula for its balancing, anti-inflammatory properties, making it especially well-suited to oily skin thanks to zinc PCA

The trial is currently on recruitment phase and efficacy parameters that will be measured include skin thickness (modified Rodnan Skin Score, mRSS), ACR CRISS score and disability questionnaires like HAQ-DI, among other outcomes (ClinicalTrials.gov identifier NCT04440592)